microdose semaglutide People are 'microdosing' weight-loss drugs—a GP explains what to watch out for GLP-1 Microdosing Chart: Tirzepatide and

Reading the table: 10 states cover GLP-1s for obesity with standard prior authorization, 3 more cover them with heavy restrictions, and several cover only a non-GLP-1 weight loss drug such as orlistat, phentermine, Qsymia, or Contrave

doi:10.1086/321262 Reynolds EH

Can J Psychiat

Pfizer Acquires a GLP-1 Pipeline and Revives FOMO Corporate Strategy Discussing Pfizer's savvy acquisition of Metsera and critiquing the GLP-1 'gap analysis' many outsiders promote as a reason all the Big Pharmas will be in GLP-1 On Monday, Pfizer PFE 0.00% announced it is acquiring Metsera MTSR 0.00% and its obesity pipeline

Centers for Disease Control and Prevention